Stephen J. Schueler, M.D.

Steinert's Disease Overview

Another name for Steinert's Disease is Muscular Dystrophy.

What is muscular dystrophy?
A person with muscular dystrophy has an inherited disorder that results in worsening muscle weakness and loss of muscle tissue. There are five main types of muscular dystrophy, each with its own features and symptoms. Duchenne's muscular dystrophy is the most common.

What are the symptoms of muscular dystrophy?
The symptoms of muscular dystrophy can vary with the underlying type. In general, muscular dystrophy causes gradually worsening muscle weakness. In the most common type of muscular dystrophy, Duchenne's muscular dystrophy, symptoms usually begin before 5 years of age. Depending on the type of muscular dystrophy, symptoms include muscle weakness, arm weakness, leg weakness, hand weakness, facial weakness, difficulty running, difficulty walking, frequent falls, enlarged muscles, muscle atrophy, and scoliosis.

How does the doctor treat muscular dystrophy?
There is no cure for muscular dystrophy. Treatment for muscular dystrophy may include weight reduction, physical therapy, corticosteroid medications, and gene therapy.

Continue to Steinert's Disease Incidence

Last Updated: Aug 20, 2010 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Steinert's Disease References
  1. Cossu G, Sampaolesi M. New therapies for muscular dystrophy: cautious optimism. Trends Mol Med. 2004 Oct;10(10):516-20. [15464452]
  2. Gregorevic P, Chamberlain JS. Gene therapy for muscular dystrophy - a review of promising progress. Expert Opin Biol Ther. 2003 Aug;3(5):803-14. [12880380]
  3. Leyten QH, Gabreels FJ, Renier WO, ter Laak HJ. Congenital muscular dystrophy: a review of the literature. Clin Neurol Neurosurg. 1996 Nov;98(4):267-80. [8930416]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.